Patents by Inventor Vladimir N. Chouljenko

Vladimir N. Chouljenko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions comprising herpes simplex virus-i for use in methods of treating and preventing cancer
    Patent number: 11975057
    Abstract: The present invention provides compositions for treating or preventing cancer and methods of using and making the compositions. The compositions comprise herpes simplex viruses comprising recombinant herpes simplex virus genomes. Further provided are recombinant herpes simplex virus genomes, viruses comprising the recombinant herpes simplex virus genomes, and cancer vaccines and other compositions comprising the viruses.
    Type: Grant
    Filed: August 1, 2019
    Date of Patent: May 7, 2024
    Assignee: Board of Supervisors of Louisiana State University Agriculture and Mechanical College
    Inventors: Konstantin G. Kousoulas, Vladimir N. Chouljenko, James Michael Mathis
  • COMPOSITIONS COMPRISING HERPES SIMPLEX VIRUS-I FOR USE IN METHODS OF TREATING AND PREVENTING CANCER
    Publication number: 20210315984
    Abstract: The present invention provides compositions for treating or preventing cancer and methods of using and making the compositions. The compositions comprise herpes simplex viruses comprising recombinant herpes simplex virus genomes. Further provided are recombinant herpes simplex virus genomes, viruses comprising the recombinant herpes simplex virus genomes, and cancer vaccines and other compositions comprising the viruses.
    Type: Application
    Filed: August 1, 2019
    Publication date: October 14, 2021
    Inventors: Konstantin G. Kousoulas, Vladimir N. Chouljenko, James Michael Mathis
  • Vaccines for infections
    Patent number: 7279171
    Abstract: Vaccine compositions protective against Chlamydia psittaci infections in animals, including but not limited to humans and avian species, comprising an immunogenic amount of a C. psittaci major outer membrane protein (MOMP) polypeptide lacking regions VD1 and VD2 are provided. Nucleic acid vectors for the expression of MOMP polypeptides and MOMP polypeptide fusion proteins are disclosed. Nucleic acid vectors encoding a C. psittaci major outer membrane protein (MOMP) polypeptide lacking regions VD1 and VD2 useful for genetic, or “naked nucleic acid” vaccination are disclosed. Methods for preventing a Chlamydia psittaci infection in a subject using MOMP polypeptides, MOMP polypeptide-fusion proteins, or nucleic acid expression vectors are also provided.
    Type: Grant
    Filed: August 11, 2003
    Date of Patent: October 9, 2007
    Assignee: Board of Supervisors of Louisiana State University and Mechanical College
    Inventors: Konstantin G. Kousoulas, Vladimir N. Chouljenko, Abolgasem Baghian, Thomas N. Tully, Jr.
  • Vaccines for Chlamydia psittaci infections
    Patent number: 6605287
    Abstract: Vaccine compositions protective against Chlamydia psittaci infections in animals, including but not limited to humans and avian species, comprising an immunogenic amount of a C. psittaci major outer membrane protein (MOMP) polypeptide lacking regions VD1 and VD2 are provided. Nucleic acid vectors for the expression of MOMP polypeptides and MOMP polypeptide fusion proteins are disclosed. Nucleic acid vectors encoding a C. psittaci major outer membrane protein (MOMP) polypeptide lacking regions VD1 and VD2 useful for genetic, or “naked nucleic acid” vaccination are disclosed. Methods for preventing a Chlamydia psittaci infection in a subject using MOMP polypeptides, MOMP polypeptide-fusion proteins, or nucleic acid expression vectors are also provided.
    Type: Grant
    Filed: August 28, 1998
    Date of Patent: August 12, 2003
    Assignee: Board of Supervisors of Louisiana State University & Agricultural and Mechanical College
    Inventors: Konstantin G. Kousoulas, Vladimir N. Chouljenko, Abolgasem Baghian, Thomas N. Tully, Jr.
  • VACCINES FOR CHLAMYDIA PSITTACI INFECTIONS
    Publication number: 20020136742
    Abstract: Vaccine compositions protective against Chlamydia psittaci infections in animals, including but not limited to humans and avian species, comprising an immunogenic amount of a C. psittaci major outer membrane protein (MOMP) polypeptide lacking regions VD1 and VD2 are provided. Nucleic acid vectors for the expression of MOMP polypeptides and MOMP polypeptide fusion proteins are disclosed. Nucleic acid vectors encoding a C. psittaci major outer membrane protein (MOMP) polypeptide lacking regions VD1 and VD2 useful for genetic, or “naked nucleic acid” vaccination are disclosed. Methods for preventing a Chlamydia psittaci infection in a subject using MOMP polypeptides, MOMP polypeptide-fusion proteins, or nucleic acid expression vectors are also provided.
    Type: Application
    Filed: August 28, 1998
    Publication date: September 26, 2002
    Inventors: KONSTANTIN G. KOUSOULAS, VLADIMIR N. CHOULJENKO, ABOLGASEM BAGHIAN, THOMAS N. TULLY, JR.